Thomas Franch is currently the Associate Vice President at Amgen, a position held since 2024. From 2012 to 2024, they served as the Chief Scientific Officer at Nuevolution, following their role as Chief Technology Officer at Nuevolution A/S from 2005 to 2012. Prior to their current role at Amgen, they were the Executive Director of Research at the company from 2019 to 2024. Thomas earned a Ph.D. in Molecular Biology from Syddansk Universitet - University of Southern Denmark, completing their studies in 1998.
This person is not in the org chart
This person is not in any teams
This person is not in any offices